HOXA5 affected tumor progression through influencing TP53 homeostasis in breast cancer (10, 38), TP53-dependent apoptosis in liposarcomas (39), and TP53-mediated cell proliferation in cervical cancer (16). Here, HOXA5 is linked to breast carcinoma.